Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Gains from Sales and Divestitures (2020)

Historic Gains from Sales and Divestitures for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2020 value amounting to $20000.0.

  • Atea Pharmaceuticals' Gains from Sales and Divestitures changed N/A to $20000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $20000.0, marking a year-over-year change of. This contributed to the annual value of $20000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Atea Pharmaceuticals reported Gains from Sales and Divestitures of $20000.0 as of Q4 2020.
  • Over the past 5 years, Atea Pharmaceuticals' Gains from Sales and Divestitures peaked at $20000.0 during Q4 2020, and registered a low of $20000.0 during Q4 2020.